RT Journal Article SR Electronic T1 Large variation in the association between seasonal antibiotic use and resistance across multiple bacterial species and antibiotic classes JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.12.21.20248670 DO 10.1101/2020.12.21.20248670 A1 Daphne S. Sun A1 Stephen M. Kissler A1 Sanjat Kanjilal A1 Scott W. Olesen A1 Marc Lipsitch A1 Yonatan H. Grad YR 2021 UL http://medrxiv.org/content/early/2021/12/29/2020.12.21.20248670.abstract AB Understanding how antibiotic use drives resistance is crucial for guiding effective strategies to limit the spread of resistance, but the use-resistance relationship across pathogens and antibiotics remains unclear. We applied sinusoidal models to evaluate the seasonal use-resistance relationship across 3 species (Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae) and 5 antibiotic classes (penicillins, macrolides, quinolones, tetracyclines, and nitrofurans) in Boston, Massachusetts. Use of all 5 classes and resistance in 9 of 15 species-antibiotic combinations showed statistically significant amplitudes of seasonality (false discovery rate < 0.05). While seasonal peaks in use varied by class, resistance in all 9 species-antibiotic combinations peaked in the winter and spring. The correlations between seasonal use and resistance thus varied widely, with resistance to all antibiotic classes being most positively correlated with use of the winter-peaking classes (penicillins and macrolides). These findings challenge the simple model of antibiotic use independently selecting for resistance and suggest that stewardship strategies will not be equally effective across all species and antibiotics. Rather, seasonal selection for resistance across multiple antibiotic classes may be dominated by use of the most highly prescribed antibiotic classes, penicillins and macrolides.Competing Interest StatementY. H. G. and M. L. have received grant support from Pfizer. S. W. O. is an employee of Biobot Analytics, Inc. The other authors declare no conflicts of interest.Funding StatementThis work was supported by funds from the HSPH Dean's Award (to Y.H.G.) and Wellcome Trust (to Y.H.G.). D.S.S. is supported by the National Institutes of Health training grant (T32AI132120).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Mass General Brigham IRB (Protocol number: 2016P001671).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data is available at: https://github.com/gradlab/use-resistance-seasonality https://github.com/gradlab/use-resistance-seasonality